Cargando…

Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model

BACKGROUND: Multiple myeloma is an incurable disease requiring the development of effective therapies which can be used clinically. We have elucidated the potential for manipulating the cAMP signaling pathway as a target for inhibiting the growth of multiple myeloma cells. METHODS: As a model system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Follin-Arbelet, Virginie, Hofgaard, Peter O, Hauglin, Harald, Naderi, Soheil, Sundan, Anders, Blomhoff, Rune, Bogen, Bjarne, Blomhoff, Heidi K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161033/ https://www.ncbi.nlm.nih.gov/pubmed/21767374 http://dx.doi.org/10.1186/1471-2407-11-301

Ejemplares similares

The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
por: Follin-Arbelet, Virginie, et al.
Publicado: (2015)

Hyperactivation of NF-κB via the MEK signaling is indispensable for the inhibitory effect of cAMP on DNA damage-induced cell death
por: Kloster, Martine M, et al.
Publicado: (2011)

A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease
por: Hofgaard, Peter O., et al.
Publicado: (2012)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements
por: Halvorsen, Bente Lise, et al.
Publicado: (2011)

Tumor-specific CD4(+) T cells eradicate myeloma cells genetically deficient in MHC class II display
por: Tveita, Anders, et al.
Publicado: (2016)

Id-neoantigen vaccine induces therapeutic CD8(+) T cells against multiple myeloma: H chain-loss escapees cause FLC MM
por: Westhrin, Marita, et al.
Publicado: (2023)

cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53
por: Skah, Seham, et al.
Publicado: (2018)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Bone marrow stroma-derived PGE(2) protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death
por: Naderi, Elin Hallan, et al.
Publicado: (2015)

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells
por: Müller, Rebekka, et al.
Publicado: (2013)

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
por: Bartee, Eric, et al.
Publicado: (2016)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Intakes of culinary herbs and spices from a food frequency questionnaire evaluated against 28-days estimated records
por: Carlsen, Monica H, et al.
Publicado: (2011)

Preclinical Evaluation of a (64)Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma
por: Métivier, Cassandra, et al.
Publicado: (2023)

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients
por: Rampa, Christoph, et al.
Publicado: (2014)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Development of the Norwegian diet index and the Norwegian lifestyle index and evaluation in a national survey
por: Henriksen, Hege Berg, et al.
Publicado: (2023)

c-Met signaling promotes IL-6-induced myeloma cell proliferation
por: Hov, Håkon, et al.
Publicado: (2009)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets
por: Kleppe, Rune, et al.
Publicado: (2018)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
por: Sponaas, Anne Marit, et al.
Publicado: (2021)

Uptake and release of amino acids in the fetal-placental unit in human pregnancies
por: Holm, Maia Blomhoff, et al.
Publicado: (2017)

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
por: Lopes, Raquel, et al.
Publicado: (2022)

Cyclic AMP dynamics in the pancreatic β-cell
por: Tengholm, Anders
Publicado: (2012)

PHYSICOCHEMICAL CHARACTERIZATION OF MOUSE MYELOMA PROTEINS: DEMONSTRATION OF HETEROGENEITY FOR EACH MYELOMA GLOBULIN
por: Fahey, John L.
Publicado: (1961)

Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model
por: Park, Bo Mi, et al.
Publicado: (2017)

CYCLIC AMP MEDIATES THE CONCANAVALIN A AGGLUTINABILITY OF MOUSE FIBROBLASTS
por: Willingham, Mark C., et al.
Publicado: (1974)

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis
por: Brenne, Anne-Tove, et al.
Publicado: (2009)

An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix
por: Ziouti, Fani, et al.
Publicado: (2020)

A Short Digital Food Frequency Questionnaire (DIGIKOST-FFQ) Assessing Dietary Intake and Other Lifestyle Factors Among Norwegians: Qualitative Evaluation With Focus Group Interviews and Usability Testing
por: Henriksen, Hege Berg, et al.
Publicado: (2022)

Experiences from multiplex PCR diagnostics of faeces in hospitalised patients: clinical significance of Enteropathogenic Escherichia coli (EPEC) and culture negative campylobacter
por: Berdal, Jan-Erik, et al.
Publicado: (2019)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
por: Starheim, K K, et al.
Publicado: (2016)

FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
por: Quist-Løkken, Ingrid, et al.
Publicado: (2023)

Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
por: Binsfeld, Marilène, et al.
Publicado: (2014)

Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma
por: Holm, Maia Blomhoff, et al.
Publicado: (2022)

Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens
por: Bekri, Selma, et al.
Publicado: (2022)

Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma
por: Wader, K F, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rk5o3bkp1vhehmfkk7dm5aenku